IP Library Granted Patent US 7,962,316
Granted Patent B2
US 7,962,316 · App. 10/577,696 · Granted Jun 14, 2011

Method of designing siRNAs for gene silencing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,962,316
App. No.
10/577,696
Granted
Jun 14, 2011
Kind
B2
Abstract

The present invention provides a method for identifying siRNA target motifs in a transcript using a position-specific score matrix approach. The invention also provides a method for identifying off-target genes of an siRNA using a position-specific score matrix approach. The invention further provides a method for designing siRNAs with higher silencing efficacy and specificity. The invention also provides a library of siRNAs comprising siRNAs with high silencing efficacy and specificity.

Claims (175)

1. A method for selecting from a plurality of different siRNAs one or more siRNAs for silencing a target gene in an organism, each different siRNA in said plurality of different siRNAs targeting a different target sequence in a transcript of said target gene, said method comprising

(a) calculating a score for a corresponding targeted sequence motif in said transcript, for each said different siRNA in said plurality of different siRNAs, wherein said score is calculated using a position-specific score matrix (PSSM), wherein each said sequence motif is a nucleotide sequence of L nucleotides, L being an integer, and wherein said PSSM is {log(e ij /p ij )}, where e ij is the weight of nucleotide i at position j, p ij is the weight of nucleotide i at position j in a random sequence, and i=G or C, A, U(T), j=1, . . . L, wherein each of said targeted sequence motifs comprises at least a portion of the target sequence of the corresponding siRNA and/or a second sequence in a sequence region flanking said target sequence;

(b) ranking said plurality of different siRNAs according to said scores; and

(c) selecting one or more siRNAs from said ranked siRNAs, wherein at least one of steps (a), (b) or (c) is performed by a suitably programmed computer.

2. The method of claim 1 , wherein each said sequence motif comprises said target sequence of said targeting siRNA.

3. The method of claim 1 , wherein said score for each said siRNA is calculated according to equation

Score

=

t

=

1

L

ln

(

e

t

/

p

t

)

wherein said e t and p t are respectively weights of the nucleotide at position t in said sequence motif as determined according to said position-specific score matrix and in a random sequence.

4. The method of claim 3 , wherein each said sequence motif comprises said target sequence of said targeting siRNA and at least one flanking sequence.

5. The method of claim 4 , wherein each said sequence motif comprises said target sequence of said targeting siRNA and a 5′ flanking sequence and a 3′ flanking sequence.

6. The method of claim 5 , wherein said 5′ flanking sequence and said 3′ flanking sequence are each a sequence of D nucleotides, D being an integer.

7. The method of claim 6 , wherein each said target sequence is a sequence of 19 nucleotides, and each said 5′ flanking sequence and 3′ flanking sequence are a sequence of 10 nucleotides.

8. The method of claim 5 , wherein each said target sequence is a sequence of 19 nucleotides, and each said 5′ flanking sequence and 3′ flanking sequence are a sequence of 50 nucleotides.

9. The method of claim 1 , further comprising a step of selecting one or more siRNAs based on silencing specificity, said step of selecting based on silencing specificity comprising, (i) for each of said plurality of siRNAs, predicting off-target genes of said siRNA from among a plurality of genes, wherein said off-target genes are genes other than said target gene and are directly silenced by said siRNA; (ii) ranking said plurality of siRNAs according to the number of off-target genes; and (iii) selecting one or more siRNAs for which said number of off-target genes is below a given threshold.

10. The method of claim 9 , wherein said predicting comprises (il) evaluating sequence of each of said plurality of genes based on a predetermined siRNA sequence match pattern; and (i2) predicting said gene as an off-target gene if said gene comprise a sequence that matches said siRNA based on said sequence match pattern.

11. The method of claim 10 , wherein said step of evaluating comprises identifying an alignment of said siRNA to a sequence in a gene by a low stringency FASTA alignment.

12. The method of claim 11 , wherein each said siRNA has L nucleotides in its duplex region, and wherein said match pattern is represented by a position match position-specific score matrix (pmPSSM), said position match position-specific score matrix consisting of weights of different positions in an siRNA to match transcript sequence positions in an off-target transcript {P j }, where j=1, . . . , L, P j is the weight of a match at position j.

13. The method of claim 12 , wherein said step (i1) comprises calculating a position match score pmScore according to equation

pmScore

=

i

=

1

L

ln

(

E

i

/

0.25

)

where E i =P i if position i is a match and E i =(1-P i )/3 if position i is a mismatch; and said step (i2) comprises predicting said gene as an off-target gene if said position match score is greater than a given threshold.

14. The method of claim 13 , wherein L is 19, and wherein said pmPSSM is given by Table I.

15. The method of claim 14 , wherein said plurality of genes comprises all known unique genes of said organism other than said target gene.

16. The method of claim 7 , wherein said position-specific score matrix (PSSM) is obtained by a method comprising

(aa) identifying a plurality of N siRNAs consisting of siRNAs having 19-nucleotide duplex region and having a silencing efficacy above a chosen threshold;

(bb) identifying for each said siRNA a functional sequence motif, said functional sequence motif comprising a 19-nucleotide target sequence of said siRNA and a 10-nucleotide 5′ flanking sequence and a 10-nucleotide 3′ flanking sequence;

(cc) calculating a frequency matrix {f ij }, where i=G, C, A, U(T); j=1, 2, . . . , L, and where f ij is the frequency of the ith nucleotide at the jth position, based on said siRNAs functional sequence motifs according to equation

f

ij

=

k

=

1

N

δ

ik

(

j

)

,

where

δ

ik

(

j

)

=

{

1

,

if

k

=

i

0

,

if

k

i

,

and

(dd) determining said PSSM by calculating e ij according to equation

e

ij

=

f

ij

N

.

17. The method of claim 16 , wherein said plurality of N siRNAs target a plurality of different genes having different transcript abundances in a cell.

18. The method of claim 17 , wherein said step (c) is carried out by selecting one or more siRNAs having the highest scores.

19. The method of claim 17 , wherein said step (c) is carried out by selecting one or more siRNAs having a score closest to a predetermined value, wherein said predetermined value is the score value corresponding to the maximum median silencing efficacy of a plurality of siRNA sequence motifs.

20. The method of claim 19 , wherein said plurality of siRNA sequence motifs are sequence motifs in transcript having abundance level of less than about 3-5 copies per cell.

21. The method of claim 17 , wherein said step (c) is carried out by selecting one or more siRNAs having a score within a predetermined range, wherein said predetermined range is a score range corresponding to a plurality of siRNAs sequence motifs having a given level of silencing efficacy.

22. The method of claim 21 , wherein said silencing efficacy is above 50% at an siRNA dose of about 100 nM.

23. The method of claim 22 , wherein said plurality of siRNA sequence motifs are sequence motifs in transcript having abundance level of less than about 3-5 copies per cell.

24. The method of claim 1 , wherein said position-specific score matrix (PSSM) is obtained by a method comprising

(aa) initializing said PSSM with random weights;

(bb) selecting randomly a weight w ij obtained in (aa);

(cc) changing the value of said selected weight to generate a test psPSSM comprising said selected weight having said changed value;

(dd) calculating a score for each of a plurality of siRNAs functional sequence motifs using said test PSSM according to equation

Score

=

k

=

1

L

ln

(

w

k

/

p

k

)

wherein said w k and p k are respectively weights of a nucleotide at position k in said functional sequence motif and in a random sequence;

(ee) calculating correlation of said score and a metric of a characteristic of an siRNA among said plurality of siRNAs functional sequence motifs;

(ff) repeating steps (cc)-(ee) for a plurality of different values of said selected weight in a given range and retain the value that corresponds to the best correlation for said selected weight; and

(gg) repeating steps (bb)-(ff) for a chosen number of times; thereby determining said PSSM.

25. The method of claim 24 , further comprising selecting said plurality of siRNA functional sequence motifs by a method comprising

(i) identifying a plurality of siRNAs consisting of siRNAs having different values in said metric;

(ii) identifying a plurality of siRNA functional sequence motifs each corresponding to an siRNA in said plurality of siRNAs.

26. The method of claim 25 , wherein said characteristic is silencing efficacy.

27. The method of claim 26 , wherein said plurality of N siRNAs target a plurality of different genes having different transcript abundances in a cell.

28. The method of claim 27 , wherein said step (c) is carried out by selecting one or more siRNAs having the highest scores.

29. The method of claim 27 , wherein said step (bb) is carried out by selecting one or more siRNAs having a score closest to a predetermined value, wherein said predetermined value is the score value corresponding to the maximum median silencing efficacy of a plurality of siRNA sequence motifs.

30. The method of claim 29 , wherein said plurality of siRNA sequence motifs are sequence motifs in transcript having abundance level of less than about 3-5 copies per cell.

31. The method of claim 27 , wherein said step (bb) is carried out by selecting one or more siRNAs having a score within a predetermined range, wherein said predetermined range is a score range corresponding to a plurality of siRNAs sequence motifs having a given level of silencing efficacy.

32. The method of claim 31 , wherein said silencing efficacy is above 50% at an siRNA dose of about 100 nM.

33. The method of claim 32 , wherein said plurality of siRNA sequence motifs are sequence motifs in transcript having abundance level of less than about 3-5 copies per cell.

34. The method of claim 24 , wherein said position-specific score matrix (PSSM) comprises w k , k=1, . . . , L, w k being a difference in probability of finding nucleotide G or C at sequence position k between a first type of siRNA and a second type of siRNA, and wherein said score for each said strand is calculated according to equation

Score

=

k

=

1

L

w

k

.

35. The method of claim 34 , wherein said first type of siRNA consists of one or more siRNAs having silencing efficacy no less than a first threshold and said second type of siRNA consists of one or more siRNAs having silencing efficacy less than a second threshold.

36. The method of claim 35 , wherein said difference in probability is described by a sum of Gaussian curves, each of said Gaussian curves representing the difference in probability of finding a G or C at a different sequence position.

37. The method of claim 36 , wherein said first and second thresholds are both 75% at an siRNA dose of 100 nM.

Assignments (5)
MERGER Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
CHANGE OF NAME Recorded Mar 17, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 024090/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2010
From: ROSETTA INPHARMATICS LLC
To: MERCK & CO., INC.
Reel/Frame 024080/0426 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT APPLICATION NUMBER IN THE ASSIGNMENT AND THE RECORDATION COVER SHEET FROM <10/557,696> TO <10/577,696> PREVIOUSLY RECORDED ON REEL 019024 FRAME 0423. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF THE INVENTION DESCRIBED AND CLAIMED IN APPLICATION NO. 10/577,696. Recorded Mar 11, 2010
From: JACKSON, AIMEE L.; BARTZ, STEVEN R.; BURCHARD, JULJA; LINSLEY, PETER S.; GE, WEI; CAVET, GUY L.
To: ROSETTA INPHARMATICS LLC
Reel/Frame 024069/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2007
From: JACKSON, AIMEE L.; BARTZ, STEVEN R.; BURCHARD, JULJA; LINSLEY, PETER S.; GE, WEI; CAVET, GUY L.
To: ROSETTA INPHARMATICS LLC
Reel/Frame 019024/0423 →